The Datos Remote Care platform frees pharma and CROs (Clinical Research Companies) to focus on development and testing of new drugs, while providing the support they need to assess data and medication adherence, and help rapidly detect and act on adverse events.
Datos features an intuitive, patient-friendly interface that keeps research and trial participants engaged throughout the duration of study processes, and assists them in maintaining close contact with research teams. This ultimately increases their adherence to research protocols, and reduces overall patient churn. The Datos platform helps maximize trial participation, and shorten research time-to-market – all while keeping costs down.
Propelling oncology research and care to the next level
Driving cardiology drug effectiveness through outcome-centric care